Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT01307267What this trial is testingPF-05082566 As A Single Agent And In Combination With RituximabWho this might be right forLymphoma, Non-HodgkinLymphoma, FollicularLymphoma, Large B-Cell, Diffuse+4 more Pfizer 190
Early research (Phase 1)Active Not RecruitingNCT01590069What this trial is testingAerosolized Aldesleukin in Treating Patients With Lung MetastasesWho this might be right forMetastatic Malignant Neoplasm in the LungMetastatic MelanomaMetastatic Osteosarcoma+5 more M.D. Anderson Cancer Center 70
Not applicableStudy completedNCT01773655What this trial is testingClinical and Histopathologic Characteristics of BAP1 MutationsWho this might be right forMalignant Pleural Mesothelioma (MPM)Choroidal NevusPrimary Uveal Melanoma (UM)+3 more Memorial Sloan Kettering Cancer Center 196
Not applicableLooking for participantsNCT05231655What this trial is testingEx VIvo DEtermiNed Cancer TherapyWho this might be right forBladder CancerKidney CancerMelanoma+3 more Sheffield Teaching Hospitals NHS Foundation Trust 600
Early research (Phase 1)Study completedNCT03517488What this trial is testingXmAb®20717 in Subjects With Selected Advanced Solid TumorsWho this might be right forMelanomaBreast CarcinomaHepatocellular Carcinoma+25 more Xencor, Inc. 150
Not applicableNot Yet RecruitingNCT07689812What this trial is testingRandomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.Who this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more Natera, Inc. 920
Not applicableStudy completedNCT04670445What this trial is testingImproving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerWho this might be right forStage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more Massachusetts General Hospital 199
Early research (Phase 1)Study completedNCT04773951What this trial is testingA Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid TumorsWho this might be right forMelanomaRenal CarcinomaUrothelial Carcinoma Shanghai Junshi Bioscience Co., Ltd. 47
Not applicableLooking for participantsNCT05621837What this trial is testingQuantifying Systemic Immunosuppression to Personalize Cancer TherapyWho this might be right forMelanomaBreast CancerRenal Cell Carcinoma+4 more Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 1,000
Early research (Phase 1)Study completedNCT00625456What this trial is testingSafety Study of Recombinant Vaccinia Virus to Treat Refractory Solid TumorsWho this might be right forMelanomaLung CancerRenal Cell Carcinoma+1 more Jennerex Biotherapeutics 23
Testing effectiveness (Phase 2)Study completedNCT03548467What this trial is testingEvaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic CancerWho this might be right forLocally Advanced or Metastatic Solid Tumours Nykode Therapeutics ASA 41
Early research (Phase 1)Ended earlyNCT01457131What this trial is testingModified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic CancerWho this might be right forMetastatic CancerMetastatic MelanomaMetastatic Renal Cancer National Cancer Institute (NCI) 2
Early research (Phase 1)Study completedNCT00001683What this trial is testingA Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic CancerWho this might be right forLymphomaMelanomaNeoplasm Metastasis+1 more National Cancer Institute (NCI) 35
Not applicableLooking for participantsNCT06967961What this trial is testingResearch of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic CancersWho this might be right forUrothelial CarcinomaRenal CancerProstate Adenocarcinoma+7 more Institut Claudius Regaud 450
Testing effectiveness (Phase 2)WithdrawnNCT04648826What this trial is testingAerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial MalignanciesWho this might be right forSarcomasMelanomasGerm Cell Tumors+2 more National Cancer Institute (NCI)
Early research (Phase 1)UnknownNCT03086174What this trial is testingTolerability and Pharmacokinetics of Toripalimab in Combination With Axitinib in Patients With Kidney Cancer and MelanomaWho this might be right forKidney Cancer Stage IvAdvanced Melanoma Shanghai Junshi Bioscience Co., Ltd. 24
Early research (Phase 1)Study completedNCT02166255What this trial is testingAPN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryWho this might be right forRecurrent MelanomaRecurrent Pancreatic CancerRecurrent Renal Cell Cancer+9 more Wake Forest University Health Sciences 17
Early research (Phase 1)Active Not RecruitingNCT03816332What this trial is testingTacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic CancersWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+18 more National Cancer Institute (NCI) 12
Not applicableNo Longer AvailableNCT03554434What this trial is testingAn Expanded Access Program for AM0010 (Pegilodecakin)Who this might be right forMelanomaProstate CancerOvarian Cancer+6 more Eli Lilly and Company